MoneyWorks4Me

Bajaj Healthcare - Quaterly Results

17 May 2022 Evaluate
The Sales for the quarter ended March 2022 of Rs. 1757.14 millions rose by 32.93% from Rs. 1321.82 millions.The Net Profit of the company registered a slight decline of -17.88% to Rs. 174.73  millions from Rs. 212.78 millions.Operating profit for the quarter ended March 2022 decreased to 256.55 millions as compared to 367.73 millions of corresponding quarter ended March 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 1757.14 1321.82 32.93 6798.89 6569.84 3.49 6798.89 6569.84 3.49
Other Income 4.48 21.52 -79.18 14.44 69.13 -79.11 14.44 69.13 -79.11
PBIDT 256.55 367.73 -30.23 1199.45 1432.39 -16.26 1199.45 1432.39 -16.26
Interest 44.86 21.52 108.46 126.24 82.96 52.17 126.24 82.96 52.17
PBDT 211.69 346.21 -38.86 1073.21 1349.43 -20.47 1073.21 1349.43 -20.47
Depreciation 42.39 44.29 -4.29 176.36 161.24 9.38 176.36 161.24 9.38
PBT 169.30 301.92 -43.93 896.85 1188.19 -24.52 896.85 1188.19 -24.52
TAX -5.43 89.14 -106.09 182.98 357.11 -48.76 182.98 357.11 -48.76
Deferred Tax -7.85 17.03 -146.10 -6.14 4.99 -223.05 -6.14 4.99 -223.05
PAT 174.73 212.78 -17.88 713.87 831.08 -14.10 713.87 831.08 -14.10
Equity 137.99 137.99 0.00 137.99 137.99 0.00 137.99 137.99 0.00
PBIDTM(%) 14.60 27.82 -47.52 17.64 21.80 -19.08 17.64 21.80 -19.08
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..